What does an echocardiogram with ejection fraction 65%, mild left ventricular hypertrophy, left ventricular outflow tract gradient 8 mmHg at rest increasing to 15 mmHg with Valsalva, mid‑cavity gradient 6 mmHg at rest increasing to 24 mmHg with Valsalva, mild mitral regurgitation, mild tricuspid regurgitation, normal right‑ventricular systolic pressure, and grade‑1 diastolic dysfunction indicate?

Hypertrophic Cardiomyopathy with Mid-Cavity Obstruction

This echocardiogram indicates hypertrophic cardiomyopathy (HCM) with provocable mid-cavity obstruction that becomes hemodynamically significant with Valsalva (24 mmHg gradient), though the LVOT gradient remains below the threshold for septal reduction therapy.

Key Diagnostic Features

The constellation of findings—mild LVH, preserved EF (65%), and dynamic gradients that increase with Valsalva—is diagnostic of HCM. The critical finding here is the mid-cavity gradient of 24 mmHg with Valsalva, which represents dynamic intraventricular obstruction distinct from typical LVOT obstruction 1.

Gradient Interpretation

• LVOT gradient: 8 mmHg at rest → 15 mmHg with Valsalva (non-obstructive)
• Mid-cavity gradient: 6 mmHg at rest → 24 mmHg with Valsalva (provocable obstruction)
• Neither gradient reaches the ≥50 mmHg threshold that defines hemodynamically significant obstruction requiring consideration for septal reduction therapy 1, 2

The 2024 AHA/ACC guidelines emphasize that resting echocardiography underestimates obstruction in up to 50% of patients, and provocative maneuvers are essential 1. However, Valsalva can be variable and may still underestimate exercise-induced gradients 3.

Clinical Significance and Next Steps

Exercise Testing is Indicated

You must perform exercise stress echocardiography because:

1. The 2024 guidelines recommend exercise echo for asymptomatic patients without resting/provocable gradients ≥50 mmHg to detect and quantify dynamic LVOTO 1
2. Research demonstrates that 70% of HCM patients have obstruction when properly assessed, with exercise revealing significant gradients in patients who appear non-obstructive at rest 3
3. The mid-cavity gradient of 24 mmHg with Valsalva suggests this patient may develop hemodynamically significant obstruction (≥50 mmHg) with physiologic exercise 3

Associated Findings Requiring Attention

Grade 1 diastolic dysfunction: While traditionally considered "mild," recent evidence shows this is not benign. Grade 1 DD is associated with increased cardiovascular mortality (HR 2.43) and may indicate elevated LVEDP despite normal mean left atrial pressure 4, 5. The combination of LVH and Grade 1 DD predicts higher filling pressures and worse outcomes 6.

Mild mitral and tricuspid regurgitation: In HCM, MR is often secondary to systolic anterior motion (SAM) of the mitral valve, though your gradients suggest this is not severe. The mild TR with normal RVSP is reassuring but should be monitored, as TR can worsen ventricular interaction and diastolic function 7, 8.

Management Algorithm

1. Perform exercise stress echocardiography to assess for exercise-induced gradients ≥50 mmHg 1, 2
2. If exercise gradient ≥50 mmHg with symptoms: Consider medical therapy (beta-blockers, disopyramide) or septal reduction therapy
3. If exercise gradient <50 mmHg: Serial TTE every 1-2 years; extend interval if clinically stable 1
4. Screen first-degree relatives with TTE as part of family screening 1
5. Monitor diastolic function closely given the prognostic implications of Grade 1 DD 5

Critical Pitfalls to Avoid

• Do not assume non-obstructive disease based on Valsalva alone—exercise testing is mandatory to exclude significant obstruction 1, 3
• Do not dismiss Grade 1 DD as "normal aging"—it carries independent cardiovascular risk 5
• Do not overlook mid-cavity obstruction—this variant of HCM requires the same systematic evaluation as LVOT obstruction 1
• Do not delay family screening—first-degree relatives need echocardiographic evaluation 1

The hyperdynamic EF (65%) in the setting of LVH and diastolic dysfunction is consistent with HCM physiology and paradoxically associated with worse diastolic properties and outcomes compared to normal EF 9.